Back
Intellia Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
NTLA
Intellia Therapeutics, Inc.
Last Price:
$11.64
Seasonality Move:
-8.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.28 | Sell |
| 20-day SMA: | 13.08 | Sell |
| 50-day SMA: | 10.93 | Buy |
| 200-day SMA: | 11.96 | Buy |
| 8-day EMA: | 12.35 | Sell |
| 20-day EMA: | 12.4 | Sell |
| 50-day EMA: | 11.98 | Buy |
| 200-day EMA: | 12.56 | Sell |
Intellia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 48.49 | Sell |
| Chaikin Money Flow: | 3168209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.22 - 14.04) | Sell |
| Bollinger Bands (100): | (8.12 - 19.08) | Sell |
Intellia Therapeutics, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics, Inc. Stock
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 12.00 while NTLA 8-day simple moving average is 12.28, which is a Sell signal.
-
The stock price of NTLA is 12.00 while Intellia Therapeutics, Inc. 20-day SMA is 13.08, which makes it a Sell.
-
Intellia Therapeutics, Inc. 50-day simple moving average is 10.93 while NTLA share price is 12.00, making it a Buy technically.
-
NTLA stock price is 12.00 and Intellia Therapeutics, Inc. 200-day simple moving average is 11.96, creating a Buy signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
36
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. a Buy or a Sell?
-
Intellia Therapeutics, Inc. stock is rated a SellThe current Intellia Therapeutics, Inc. [NTLA] share price is $12.00. The Score for NTLA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics, Inc. Stock Info
Market Cap:
1.4B
Price in USD:
12.00
Share Volume:
3.6M
Intellia Therapeutics, Inc. 52-Week Range
52-Week High:
28.25
52-Week Low:
5.90
Sell
36
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Intellia Therapeutics, Inc. Share Price Forecast
-
What is the Intellia Therapeutics, Inc. stock price today?The Intellia Therapeutics, Inc. stock price is 12.00 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics, Inc. is overvalued.
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 12.00 while NTLA 8-day exponential moving average is 12.35, which is a Sell signal.
-
The stock price of NTLA is 12.00 while Intellia Therapeutics, Inc. 20-day EMA is 12.40, which makes it a Sell.
-
Intellia Therapeutics, Inc. 50-day exponential moving average is 11.98 while NTLA share price is 12.00, making it a Buy technically.
-
NTLA stock price is 12.00 and Intellia Therapeutics, Inc. 200-day simple moving average is 12.56, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics, Inc.
Is Intellia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.05 per share.
Technical Analysis of Intellia Therapeutics, Inc.
Should I short Intellia Therapeutics, Inc. stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Intellia Therapeutics, Inc. is a Buy
-
Intellia Therapeutics, Inc. Relative Strength Index (RSI) is 48.49, which suggest Intellia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics, Inc. is (11.22 - 14.04), which suggest Intellia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics, Inc. is (8.12 - 19.08), which suggest Intellia Therapeutics, Inc. is a Sell
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.